Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of pneumonia in humans, and it is associated with high morbidity and mortality rates, especially in immunocompromised patients. Its high rate of multidrug resistance led to an exploration of novel antimicrobials. Metal nanoparticles have shown potent antibacterial activity, thus instigating their application in MRSA. This review summarizes current insights of Metal-Containing NPs in treating MRSA. This review also provides an in-depth appraisal of opportunities and challenges in utilizing metal-NPs to treat MRSA.

/pdf/a-metal-containing-np-approach-to-treat-methicillin-1xo4xmvd.pdf

A Metal-Containing NP Approach to Treat Methicillin-Resistant Staphylococcus aureus (MRSA): Prospects and Challenges

Nanomaterials in drug delivery systems are emerging as a potential source of treatments. The bioavailability of nano-carriers depends upon various factors including their mode of administration, target specificity, availability of active compound and compatibility with biological system.

/pdf/a-short-review-on-advances-in-nanosystems-emerging-as-an-2efmioecge.pdf

Tripathi Ashutosh

Papers

A Short Review on Advances in Nanosystems Emerging as an Effective Approaches to Control Pathogenesis of Staphylococcus spp